PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
31976547-10	2020	Moreover, luteolin treatment mitigated irinotecan-induced oxidative stress (i.e. by reducing the levels of ROS and LOOH, and augmenting endogenous antioxidants) and inflammation (i.e. through the decrease of MPO enzyme activity, TNF, IL-1beta, and IL-6 levels; and increasing IL-4 and IL-10).	Luteolin	10-18	interleukin 6	Mus musculus	248-252	
26002582-10	2015	Luteolin administration significantly decreased acetaminophen-induced serum alanine aminotransferase (ALT), aspartate aminotransferase (AST), tumor necrosis factor alpha (TNF-alpha), interleukin 6 (IL-6), malondialdehyde (MDA) levels, as well as glutathione (GSH) depletion and decrease of superoxide dismutase (SOD).	Luteolin	0-8	interleukin 6	Mus musculus	183-196	
31302373-6	2019	Luteolin supplementation also significantly lowered mRNA expression of inflammatory and M1 markers MCP-1, CD11c, TNF-alpha and IL-6, while maintaining expression of M2 marker MGL1.	Luteolin	0-8	interleukin 6	Mus musculus	127-131	
32269953-1	2020	Objective: To investigate the mechanism of the adaptive effect of two compounds in Lonicerae japonica flos (LJF), luteolin (LUT) and chlorogenic acid (CGA), on the expression of interleukin (IL) IL-10 and IL-6.	Luteolin	114-122	interleukin 6	Mus musculus	205-209	
26002582-10	2015	Luteolin administration significantly decreased acetaminophen-induced serum alanine aminotransferase (ALT), aspartate aminotransferase (AST), tumor necrosis factor alpha (TNF-alpha), interleukin 6 (IL-6), malondialdehyde (MDA) levels, as well as glutathione (GSH) depletion and decrease of superoxide dismutase (SOD).	Luteolin	0-8	interleukin 6	Mus musculus	198-202	
20958047-5	2010	We found that oral administration of luteolin (10 mg/kg) efficiently suppressed the neutrophil infiltration as well as TNF-alpha and IL-6 elevation in the bronchoalveolar lavage fluid in bleomycin-instilled C57BL/6J mice.	Luteolin	37-45	interleukin 6	Mus musculus	133-137	
34790666-10	2021	We found that oral administration of luteolin (10 mg/Kg) for eight consecutive days could decrease the immobility time on tail suspension test, a mouse behavioral test measuring depression-like behavior, and attenuate LPS-induced inflammatory responses by significantly decreasing IL-6 production in mice brain-derived astrocytes and serum, and TNFalpha and corticosterone levels in serum.	Luteolin	37-45	interleukin 6	Mus musculus	281-285